Home
Goodwin Procter LLP
Elaine Herrmann Blais
Elaine Herrmann Blais
Goodwin Procter LLP
REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition
04 Apr 2024 | United States
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
16 Jan 2024 | United States
Genentech Files BPCIA Complaint Against Biogen Regarding Tocilizumab
18 Jul 2023 | United States
Coherus And AbbVie File Dueling Motions For Injunctive Relief Relating To Coherus's HUMIRA Biosimilar
29 Jun 2023 | United States
Update On Arbutus MRNA Vaccine Patent Litigations
17 Apr 2023 | United States
Year In Review: Top Deals In 2022
11 Jan 2023 | United States
Year In Review: Top Legal Developments Of 2022
10 Jan 2023 | United States
Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusionary Campaign To Deny Patients Access To Praluent®
03 Jun 2022 | United States
America Invents Act Signed Into Law
11 Oct 2011 | United States
America Invents Act Expected To Be Signed Into Law Next Week
13 Sep 2011 | United States
Therasense Decision Raises Bar For Proving Inequitable Conduct
12 Jul 2011 | United States
Supreme Court Decides Clear And Convincing Evidence Necessary For All Patent Validity Challenges
15 Jun 2011 | United States
U.S. Senate Approves America Invents Act
01 Apr 2011 | United States
Contact Details
Boston
Email Website
Boston
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.